Atlas Trials

Gastric Cancer Stage IV

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastric Cancer Stage IV

RecordFirmDate
Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab. (NCT05301465)University of Pisa2021-11-01
Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis (NCT05204173)Ruijin Hospital2021-05-20
Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC (NCT06034964)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2020-11-01
Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer (NCT04563975)Tao Zhang2020-07-02
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer (NCT04267549)Tianjin Medical University Cancer Institute and Hospital2019-05-01
Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 (NCT03618758)Seoul National University Bundang Hospital2018-12-24
PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. (NCT03755440)Sun Yat-sen University2018-12-01
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors (NCT03159585)Zhujiang Hospital2017-04-14
Maintenance Treatment With S-1 in Gastric Cancer Patients (NCT03701373)Sun Yat-sen University2016-01-01
Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer (NCT06666582)Hellenic Cooperative Oncology Group2015-03-01
Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer (NCT07009600)Samsung Medical Center2010-01-01

Track Gastric Cancer Stage IV automatically

Every clearance here is in the API, with alerts when new ones post.